Guna-diur Solution/ Drops
FDA Label NDC 17089-260

18 label sections · Submitted to the FDA by Guna Spa · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Guna Spa for the product Guna-diur (NDC 17089-260). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1. indications and usage, 2. dosage and administration, 3. dosage forms and strengths, 4. contraindications, 5. warnings and precautions, 6. adverse reactions, 7. drug interactions, 8. use in specific populations, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

6. Adverse Reactions

6.1.    None known (see CONTRAINDICATIONS for hypersensitivity information).

7. Drug Interactions

7.1.    None Known

9. Drug Abuse And Dependence

9.1.    No Known.

10. Overdosage

10.1.    No Known.

15. References

15.1.    H.H. Reckeweg. Homeopathic Materia Medica.  Aurelia Verlag.
15.2.    Boericke,  William,  Materia  Medica  with  Reperatory,  1927,  ninth edition

17. Patient Counseling Information

17.1.    Patients should be informed about Homeopathy and the main differences with conventional clinical approaches.

* Please review the disclaimer below.